The expanded center, measuring 806 square meters, leverages MilliporeSigma’s world-class technical and application expertise. It includes a simulated manufacturing environment and enables collaboration with MilliporeSigma experts to evaluate processes and accelerates development and production of new therapies. In addition, education on best practices and new approaches to develop, optimize and scale-up processes and ways to simplify global technology transfer will be available to customers.
“Bangalore is a hub for India’s rapidly growing biopharmaceutical manufacturing industry,” said Udit Batra, Member of the Executive Board, Merck KGaA, Darmstadt, Germany, CEO MilliporeSigma. “With the expansion of our M Lab™ Collaboration Center in Bangalore, we are providing customers with hands-on experience and customized support required to optimize their manufacturing processes to quickly bring much-needed therapies to patients.”
The new M Lab™ Collaboration Center in Bangalore is one of nine such centers around the world. Each center helps customers, government collaborators, academia, regulatory bodies and industry associations to increase their productivity, mitigate risk and improve processes with the help of an industry-leading team of MilliporeSigma experts. Customers have access to sizing and simulation tools and methodologies, analytical and modelling support, training sessions and educational programs.
Click here to learn more about the M Lab™ Collaboration Centers and MilliporeSigma’s new, expanded center in Bangalore.